Behçet Uveitis in the American Midwest

REFERENCES

• Behçet H. Überrezidivierendeaphthösedurchein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatol Wochenschr. 1937;105:1152–1157.
   Google Scholar
• Michelson JB, Chisari FV. Behçet’s disease. Surv Ophthalmol. 1982;26(4):190–203.
   Google Scholar
• Elisseeff, V. Approaches old, and new to the Silk Roads., In: The Silk Roads: Highways of Culture and Commerce., Paris: UNESCO; 1998. Reprint: Berghahn Books; 2009: 1–2. ISBN 978-92-3-103652-1.
   Google Scholar
• Ohno S, Ohguchi M, Hirose S, et al. Close association of HLA-Bw51 with Behçet’s disease. Arch Ophthalmol. 1982;100(9):1455–1458.
   Google Scholar
• Behçet’s Disease Research Committee of Japan. Behçet’s disease: guide to diagnosis of Behçet’s disease. Jpn J Ophthalmol. 1974;18:291–294.
   Google Scholar
• International Study Group for Behç, et’s disease. Criteria for diagnosis of Behçet’s disease. Lancet. 1990;335(8697):1078–1080.
   Google Scholar
• Kural-Seyahi E, Fresko I, Seyahi N, et al. The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine. 2003;82(1):60–76.
   PubMed Web of Science ®Google Scholar
• Yazici H, Fresko I, Yurdakul S. Behçet’s syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol. 2007;3(3):148–155.
   Google Scholar
• Gül A. Behçet’s disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy. 2005;4(1):81–83.
   PubMedGoogle Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509–516.
   PubMed Web of Science ®Google Scholar
• Goldstein DA, Fontanilla FA, Kaul S, et al. Long-term follow-up of patients treated with short-term high-dose chlorambucil for sight-threatening ocular inflammation. Ophthalmology. 2002;109(2):370–377.
   PubMed Web of Science ®Google Scholar
• James DG. Behçet’s disease. QJM. 2010;103(3):205.
   Google Scholar
• Verity DH, Marr JE, Ohno S, et al. Behçet’s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens. 1999;54(3):213–220.
   PubMedGoogle Scholar
• Kitaichi N, Miyazaki A, Iwata D, et al. Ocular features of Behcet’s disease: an international collaborative study. Br J Ophthalmol. 2007;91(12):1579–1582.
   PubMed Web of Science ®Google Scholar
• De Menthon M, Lavalley MP, Maldini C, et al. HLA-B51/B5 and the risk of Behçet’s disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum. 2009;61(10):1287–1296.
   Google Scholar
• Baricordi OR, Sensi A, Pivetti-Pezzi P, et al. Behçet’s disease associated with HLA-B51 and DRw52 antigens in Italians. Hum Immunol. 1986;17(3):297–301.
   Google Scholar
• Chung YM, Lin YC, Tsai CC, et al. Behçet’s disease with uveitis in Taiwan. J Chin Med Assoc. 2008;71(10):509–516.
   Google Scholar
• Ambresin A, Tran T, Spertini F, et al. Behçet’s disease in western Switzerland: epidemiology and analysis of ocular involvement. Ocul Immunol Inflamm. 2002;10(1):53–63.
   Google Scholar
• Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, et al. Uveitis in Behçet disease: an analysis of 880 patients Am J Ophthalmol. 2004;138(3):373–380.
   Google Scholar
• Khairallah M, Attia S, Yahia SB, et al. Pattern of uveitis in Behçet’s disease in a referral center in Tunisia, North Africa. Int Ophthalmol. 2009;29(3):135–141.
   PubMedGoogle Scholar
• Alpsoy E, Donmez L, Onder M, et al. Clinical features and natural course of Behçet’s disease in 661 cases: a multicentre study. Br J Dermatol. 2007;157(5):901–906.
   Google Scholar
• Krause L, Köhler AK, Altenburg A, et al. Ocular involvement in Adamantiades-Behçet’s disease in Berlin, Germany. Graefes Arch Clin Exp Ophthalmol. 2009:247(5):661–666.
   PubMed Web of Science ®Google Scholar
• Yang P, Fang W, Meng Q, et al. Clinical features of Chinese patients with Behçet’s disease. Ophthalmology. 2008;115(2):312–318.
   PubMed Web of Science ®Google Scholar
• Sáenz-Francés F, Elías-de-Tejada M, Martínez-de-la-Casa JM, et al. Ocular inflammatory signs observed in a cohort of Spanish patients with Behçet disease and ocular inflammation. Eur J Ophthalmol. 2008;18(4):563–566.
   PubMedGoogle Scholar
• Barra C, Belfort Jú,nior R, Abreu MT, et al. Behçets disease in Brazil—a review of 49 cases with emphasis on ophthalmic manifestations. Jpn J Ophthalmol. 1991;35(3):339–346.
   Google Scholar
• Benezra D, Cohen E. Treatment and visual prognosis in Behçets disease. Br J Ophthalmol. 1986;70(8):589–592.
   Google Scholar
• Mishima S, Masuda K, Izawa Y, et al. The eighth Frederick H Verhoeff Lecture. Behçet’s disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc. 1979;77:225–279.
   PubMedGoogle Scholar
• Sungur G, Hazirolan D, Hekimoglu E, et al. Late-onset Behçet’s disease: demographic, clinical, and ocular features. Graefes Arch Clin Exp Ophthalmol. 2010;248(9):1325–1330.
   Google Scholar
• Ng CH, Cheung N, Wang JJ, et al. Prevalence and risk factors for epiretinal membranes in a multi-ethnic United States population. Ophthalmology. 2011 Apr;118(4):694–699.
   Google Scholar
• Kawasaki R, Wang JJ, Mitchell P, et al. Racial difference in the prevalence of epiretinal membrane between Caucasians and Asians. Br J Ophthalmol. 2008 Oct;92(10):1320–1324.
   Google Scholar
• Kawasaki R, Wang JJ, Sato H, et al. Prevalence and associations of epiretinal membranes in an adult Japanese population: the Funagata study. Eye (Lond). 2009 May;23(5):1045–1051.
   Google Scholar
• Fraser-Bell S, Ying-Lai M, Klein R, et al. Prevalence and associations of epiretinal membranes in Latinos: the Los Angeles Latino Eye Study. Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1732–1736.
   Google Scholar
• Mitchell P, Smith W, Chey T, et al. Prevalence and associations of epiretinal membranes: The Blue Mountains Eye Study, Australia. Ophthalmology. 1997 Jun;104(6):1033–1040.
   Google Scholar